Integrin α_vβ₃-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy

Huan Xie1 Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, USA

Parmeswaran Diagaradjane2 Department of Radiation Oncology, Division of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA

Amit A Deorukhkar2 Department of Radiation Oncology, Division of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA

Beth Goins3 Department of Radiology, the University of Texas Health Science Center at San Antonio (UTHSC-San Antonio), San Antonio, TX, USA

Ande Bao3 Department of Radiology, the University of Texas Health Science Center at San Antonio (UTHSC-San Antonio), San Antonio, TX, USA

William T Phillips3 Department of Radiology, the University of Texas Health Science Center at San Antonio (UTHSC-San Antonio), San Antonio, TX, USA

Zheng Wang4 MPI Research, Inc., Mattawan, MI, USA

Jon Schwartz5 Nanospectra Biosciences, Inc., Houston, TX, USA

Sunil Krishnan2 Department of Radiation Oncology, Division of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]

show all

Integrin α_vβ₃-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Integrin αvβ3-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Integrin α_vβ₃-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy